(Total Views: 109)
Posted On: 10/09/2020 10:07:46 AM
Post# of 126932
$HALB Halberd Corporation CEO Update Letter – & More
* Secured license to two issued patents on an extracorporeal treatment
process, previously held by Premier Biomedical.
* Established Coronavirus as clinical target for extracorporeal patent application.
* Secured license to three provisional patent applications for Coronavirus work.
* Secured required non-dilutive funding to start work at a research facility.
http://www.thestreetnow.com/spotlight/halb/
* Secured license to two issued patents on an extracorporeal treatment
process, previously held by Premier Biomedical.
* Established Coronavirus as clinical target for extracorporeal patent application.
* Secured license to three provisional patent applications for Coronavirus work.
* Secured required non-dilutive funding to start work at a research facility.
http://www.thestreetnow.com/spotlight/halb/
(0)
(0)
